Maslak P - Search Results

1

Using the hemoglobin content of reticulocytes (RET-He) to evaluate anemia in patients with cancer.

Peerschke EI, Pessin MS, Maslak P. Peerschke EI, et al. Among authors: maslak p. Am J Clin Pathol. 2014 Oct;142(4):506-12. doi: 10.1309/AJCPCVZ5B0BOYJGN. Am J Clin Pathol. 2014. PMID: 25239418 Free PMC article.

2

Comparison of automated platelet counts and potential effect on transfusion decisions in cancer patients.

Marionneaux S, Francisco N, Chan V, Hanenberg J, Rafael J, Chua C, Jia R, Yao J, Lynch J, Chan V, Maslak P. Marionneaux S, et al. Among authors: maslak p. Am J Clin Pathol. 2013 Nov;140(5):747-54. doi: 10.1309/AJCP58INTITVGQZI. Am J Clin Pathol. 2013. PMID: 24124156

3

Evaluation of new automated hematopoietic progenitor cell analysis in the clinical management of peripheral blood stem cell collections.

Peerschke EI, Moung C, Pessin MS, Maslak P. Peerschke EI, et al. Among authors: maslak p. Transfusion. 2015 Aug;55(8):2001-9. doi: 10.1111/trf.13078. Epub 2015 Mar 21. Transfusion. 2015. PMID: 25808236 Free PMC article.

4

Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma.

Royston DJ, Gao Q, Nguyen N, Maslak P, Dogan A, Roshal M. Royston DJ, et al. Among authors: maslak p. Am J Clin Pathol. 2016 Jul;146(1):41-9. doi: 10.1093/ajcp/aqw052. Am J Clin Pathol. 2016. PMID: 27402608 Free PMC article.

5

Evaluation of peripheral blood mononuclear cell collection by leukapheresis.

Chen J, Goss C, Avecilla ST, Hong H, Walsh E, Wuest D, Maslak P, Pessin MS. Chen J, et al. Among authors: maslak p. Transfusion. 2019 May;59(5):1765-1772. doi: 10.1111/trf.15186. Epub 2019 Feb 12. Transfusion. 2019. PMID: 30747437 Free PMC article.

6

Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma.

Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, Zelenetz AD, Nimer SD. Moskowitz CH, et al. Among authors: maslak p. Clin Cancer Res. 1998 Feb;4(2):311-6. Clin Cancer Res. 1998. PMID: 9516916 Clinical Trial.

7

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

Schwartz GK, Ilson D, Saltz L, O'Reilly E, Tong W, Maslak P, Werner J, Perkins P, Stoltz M, Kelsen D. Schwartz GK, et al. Among authors: maslak p. J Clin Oncol. 2001 Apr 1;19(7):1985-92. doi: 10.1200/JCO.2001.19.7.1985. J Clin Oncol. 2001. PMID: 11283131 Clinical Trial.

8

Pentostatin and cyclophosphamide: an effective new regimen in previously treated patients with chronic lymphocytic leukemia.

Weiss MA, Maslak PG, Jurcic JG, Scheinberg DA, Aliff TB, Lamanna N, Frankel SR, Kossman SE, Horgan D. Weiss MA, et al. J Clin Oncol. 2003 Apr 1;21(7):1278-84. doi: 10.1200/JCO.2003.08.100. J Clin Oncol. 2003. PMID: 12663715

9

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.

Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA. Lamanna N, et al. Among authors: maslak p. J Clin Oncol. 2006 Apr 1;24(10):1575-81. doi: 10.1200/JCO.2005.04.3836. Epub 2006 Mar 6. J Clin Oncol. 2006. PMID: 16520464

10

Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.

May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA. May RJ, et al. Among authors: maslak p. Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4547-55. doi: 10.1158/1078-0432.CCR-07-0708. Clin Cancer Res. 2007. PMID: 17671141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page